Cargando…
Malignant benign hematology
When faced with a life‐threatening non‐cancerous blood disorder, the term “benign” is a misnomer. Devastating diseases like catastrophic antiphospholipid antibody syndrome, acquired hemophilia, and severe immune thrombocytopenia present a challenge to the hematologist. They are often difficult to tr...
Autor principal: | Sholzberg, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332750/ https://www.ncbi.nlm.nih.gov/pubmed/30656271 http://dx.doi.org/10.1002/rth2.12170 |
Ejemplares similares
-
Hematology in Latin America: where are we? Analysis of the reports of Societies of Hematology associated organization of the Highlights of ASH in Latin America
por: Gabús, Raul, et al.
Publicado: (2011) -
Underrepresentation and undertreatment of women in hematology: An unsolved issue
por: Liblik, Kiera, et al.
Publicado: (2022) -
Molecular Aspects of Hematological Malignancies and Benign Hematological Disorders
por: Găman, Amelia Maria
Publicado: (2023) -
Genetics of Malignant Hyperthermia: A Brief Update
por: Beebe, David, et al.
Publicado: (2020) -
Benign Neoplasm of Kidney: Angiomyolipoma
por: Wang, Shih-Feng, et al.
Publicado: (2018)